1.01 (3.84%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Neutral
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Greenwich LifeSciences, Inc.
Telephone
1.832.819.3232
Address
Building 14, 3992 Bluebonnet Drive, Stafford, TX 77477
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 7.78 - 34.1
Trade Value (12mth)
US$1,047,286.00
1 week
-3.31%
1 month
14.84%
YTD
35.13%
1 year
170.4%
All time high
158.07
EPS 3 yr Growth
243.60%
EBITDA Margin
0.00%
Operating Cashflow
-$7m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
0.00
Quick Ratio
2.60
Shares Outstanding (Fully Diluted)
14m
HALO Sector
Healthcare
Next Company Report Date
03-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 19 December 25 | |
| 19 December 25 | |
| 19 December 25 | |
| 15 November 25 | |
| 15 November 25 |
Historical data
Forecast data
| USD | 2020 | 2021 | 2022 | 2023 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.61 | -0.69 | -1.21 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.61 | -0.69 | -1.21 | | | | ||
Growth | % | | | | | -71.6 | -14.2 | -75.3 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
